Orphanet Journal of Rare Diseases
Scope & Guideline
Connecting global minds on rare conditions.
Introduction
Aims and Scopes
- Clinical Research on Rare Diseases:
This includes studies that explore clinical presentations, treatment efficacy, and long-term outcomes of various rare diseases, contributing to improved management and care protocols. - Genetic Characterization and Genomics:
The journal emphasizes studies that delve into the genetic underpinnings of rare diseases, including mutation analysis, genotype-phenotype correlations, and the use of next-generation sequencing to enhance diagnostic accuracy. - Patient-Centered Outcomes and Quality of Life:
Research focusing on patient-reported outcomes, quality of life assessments, and the psychosocial impact of rare diseases on patients and their families is a core area, highlighting the importance of patient perspectives in treatment planning. - Health Economics and Burden of Illness:
The journal publishes studies that assess the economic impact of rare diseases, including cost-of-illness analyses and healthcare utilization, providing insights into the broader implications of these conditions on healthcare systems. - Innovative Therapeutics and Treatment Approaches:
Research on novel therapeutic interventions, including pharmacological treatments, gene therapies, and clinical trial methodologies to evaluate the effectiveness of new therapies for rare diseases. - Multidisciplinary and Collaborative Approaches:
The journal promotes interdisciplinary research that involves collaboration among clinicians, researchers, and patients, fostering a holistic approach to the study and management of rare diseases.
Trending and Emerging
- Telemedicine and Remote Care:
The COVID-19 pandemic has accelerated interest in telehealth solutions for managing rare diseases, leading to an increase in studies examining the effectiveness of remote consultations and digital health technologies. - Patient Engagement and Advocacy:
There is a growing focus on the role of patient advocacy groups and their influence on research priorities and treatment development, highlighting the importance of patient voices in shaping healthcare policies. - Longitudinal and Natural History Studies:
Research tracking the long-term progression of rare diseases is gaining traction, aiming to improve understanding of disease trajectories and inform future therapeutic strategies. - Integration of Artificial Intelligence in Rare Disease Research:
The application of AI and machine learning in analyzing large datasets for rare diseases is emerging, with studies exploring how these technologies can enhance diagnostics and treatment personalization. - Health Disparities in Rare Diseases:
An increasing emphasis on understanding the disparities in access to care and treatment outcomes among different populations affected by rare diseases is becoming more prevalent.
Declining or Waning
- Epidemiological Studies of Rare Diseases:
There has been a noticeable decline in publications solely focused on the epidemiology of rare diseases, possibly due to the increasing integration of epidemiological data into broader studies that also consider genetic and clinical aspects. - Traditional Case Reports:
The frequency of traditional case reports has diminished as the journal increasingly emphasizes systematic reviews and larger cohort studies that provide more comprehensive data. - Single-Country Focused Studies:
Research that concentrates on rare diseases within a specific country is becoming less common, as there is a growing trend toward multi-national studies that provide a more global perspective on rare diseases.
Similar Journals
RMD Open
Connecting global minds in Immunology and Allergy.RMD Open, published by the BMJ Publishing Group, is a leading open-access journal that has made significant contributions to the fields of Immunology, Immunology and Allergy, and Rheumatology since its inception in 2015. With an impressive Q1 ranking in these categories for 2023, the journal has established itself as an essential platform for the dissemination of high-quality research, case studies, and reviews that advance understanding and treatment strategies in these critical areas of health. As an open-access publication, RMD Open ensures that its content is freely accessible to a global audience, promoting collaboration and knowledge sharing among researchers, clinicians, and students. Based in the United Kingdom at the British Medical Association House, RMD Open is not only dedicated to improving patient care but also to fostering innovative research and discussions in the rapidly evolving landscape of rheumatic diseases.
SAGE Open Medical Case Reports
Fostering Collaboration Through Shared Medical KnowledgeSAGE Open Medical Case Reports, published by SAGE Publications Inc, is a pioneering open-access journal dedicated to the rapid dissemination of medical case reports that significantly contribute to clinical knowledge and practice. Since its launch in 2013, this journal has become a valuable resource for healthcare professionals, researchers, and students in the field of medicine, facilitating the exchange of unique clinical experiences from around the globe. While the journal is categorized as Q4 in the Medicine (miscellaneous) quartile and holds a Scopus rank of 423 out of 636 in the General Medicine category, the accessibility of its content underscores its commitment to enhancing medical education and informing practice. With no subscription barriers, it supports the sharing of critical insights appropriate to a diverse audience, thereby fostering a culture of innovation and collaboration in healthcare.
Internal Medicine
Exploring Innovations in Internal Medicine ResearchInternal Medicine is a distinguished peer-reviewed journal published by the Japan Society of Internal Medicine, focusing on the nuanced field of internal medicine. Since its inception in 1974 and with a commitment to advancing medical knowledge, the journal has evolved remarkably, aiming to disseminate high-quality research that contributes to the understanding and treatment of internal diseases. Operating from Tokyo, Japan, it provides an intellectual platform for researchers and clinicians to publish original articles, reviews, and case studies that address various aspects of internal medicine. The journal currently holds a ranking in the Q3 quartile for both Internal Medicine and miscellaneous Medicine categories as of 2023, signifying its growing influence in the medical community. Although not an open-access journal, it remains accessible to a wide audience through institutional subscriptions, enhancing its reach among professionals and students alike. With its commitment to excellence, Internal Medicine serves as an essential resource for those seeking the latest developments and research within this vital medical field.
ACTA CLINICA BELGICA
Championing excellence in medical scholarship and practice.ACTA CLINICA BELGICA is a distinguished peer-reviewed journal published by Taylor & Francis Ltd that has been a vital contributor to the field of general medicine since its inception in 1946. With an ISSN of 1784-3286 and an E-ISSN of 2295-3337, it serves as an essential platform for disseminating novel research and clinical advancements. The journal is currently ranked in the 3rd quartile (Q3) of the Medicine (miscellaneous) category, placing it at an impressive 76th percentile among its peers in the Scopus database, which reflects its importance in the medical community. Although it does not offer Open Access options, ACTA CLINICA BELGICA provides a comprehensive overview of contemporary research, clinical practices, and medical innovations, making it a crucial resource for researchers, healthcare professionals, and students committed to enhancing their knowledge and practices.
Cold Spring Harbor Molecular Case Studies
Transforming molecular biology into clinical practice.Cold Spring Harbor Molecular Case Studies is a prestigious journal published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT, that has garnered considerable attention in the fields of Biochemistry, Genetics, and Molecular Medicine. With a focus on the intersection of molecular biology and clinical case studies, this journal serves as a key resource for researchers and practitioners seeking to explore novel insights into genetic disorders and biomedical advances. Its impact is underscored by its categorization in Q2 in various disciplines in 2023, reflecting its significance and influence within the academic community. Although currently not labeled as Open Access, Cold Spring Harbor Molecular Case Studies provides a rigorous platform for disseminating high-quality, peer-reviewed research that drives innovation and enhances understanding in these rapidly evolving fields. As a supporter of advancing scientific knowledge, this journal is essential for those dedicated to the exploration of molecular mechanisms and their clinical implications.
Clinical Medicine & Research
Exploring the frontiers of medical science for better care.Clinical Medicine & Research is a premier peer-reviewed journal published by Marshfield Clinic, dedicated to advancing the field of medical science with a focus on clinical and community-based care. Established in 2003, the journal showcases groundbreaking research and innovative practices aimed at improving patient outcomes and optimizing healthcare delivery. With an ISSN of 1539-4182 and an E-ISSN of 1554-6179, it has garnered recognition in the academic community, achieving a Q2 ranking in Community and Home Care and a Q3 ranking in Miscellaneous Medicine categories as of 2023. The journal’s Scopus rankings further emphasize its relevance, placing it at #263 in General Medicine and #20 in Community and Home Care. Although it operates under a subscription model, Clinical Medicine & Research remains pivotal for researchers, professionals, and students seeking to stay informed about the latest advancements in clinical practice and healthcare methodologies, with an eye toward its impact on the broader medical landscape through 2024 and beyond.
Boletin de Pediatria
Advancing Pediatric Knowledge for Healthier FuturesBoletin de Pediatria is a distinguished journal dedicated to the field of pediatric medicine, serving as a valuable resource for researchers, clinicians, and students alike. Published by EDICIONES ERGON SA, this journal is committed to advancing the knowledge and practice of pediatric healthcare. With its ISSN 0214-2597 and E-ISSN 2340-5384, it strives to disseminate high-quality, peer-reviewed research that addresses the latest advancements and best practices in pediatrics. Although specific impact factor data is not currently available, the journal's rigorous publication standards maintain its reputation within the scientific community. Notably, while Boletin de Pediatria is not an open-access journal, it provides digital access options that ensure the wide distribution of critical pediatric research. With a commitment to improving child health outcomes, this journal plays an essential role in fostering innovation and collaboration among pediatric healthcare professionals globally.
ZEITSCHRIFT FUR RHEUMATOLOGIE
Innovating the future of rheumatology through scholarly discourse.ZEITSCHRIFT FUR RHEUMATOLOGIE, published by Springer Heidelberg, serves as a vital platform in the field of rheumatology, providing researchers, clinicians, and students with cutting-edge findings and discussions related to the diagnosis, treatment, and management of rheumatic diseases. Since its inception in 1974 and continuing until 2024, this journal retains its commitment to disseminating significant scientific work within this specialized domain. Although it is currently categorized in the Q4 quartile for Rheumatology and ranks 47 out of 73 in Scopus, reflecting its burgeoning presence, the journal is dedicated to evolving and gaining prominence in the academic community. By offering valuable insights and fostering scholarly discourse, ZEITSCHRIFT FUR RHEUMATOLOGIE plays a crucial role in advancing rheumatology research and enhancing patient care practices worldwide. The journal presents an opportunity for its readers to engage with contemporary studies and enrich their understanding of rheumatic ailments.
Indian Journal of Rheumatology
Innovating patient care through rigorous rheumatology scholarship.Welcome to the Indian Journal of Rheumatology, a premier scholarly platform dedicated to advancing research and clinical practice in the field of rheumatology. Published by SAGE Publications Inc., this journal has been providing open access to its valuable content since 2006, promoting the dissemination of knowledge in India and beyond. As a voice in the rheumatology community, the journal addresses a wide range of topics including epidemiology, diagnostics, treatment strategies, and patient care in rheumatic diseases. Despite being classified in the Q4 category of the 2023 Scopus rankings, with a current position of Rank #57 among 73 journals, it serves as an essential resource for researchers, healthcare professionals, and students seeking to stay updated with the latest developments. The journal is committed to fostering scholarly dialogue and facilitating access to research that influences practice and improves patient outcomes in rheumatologic care.
ORVOSI HETILAP
Advancing Knowledge, Shaping PracticesORVOSI HETILAP is a pivotal journal in the field of general medicine, published by AKADEMIAI KIADO ZRT in Hungary. With its rich history dating back to 1949, this journal has been a platform for disseminating significant research findings and clinical advancements that impact healthcare practices. Although it currently falls within the Q4 category in the 2023 ranking of Medicine (miscellaneous), it holds a Scopus rank of #320 among 636 journals in its category, indicating its growing recognition among peers and scholars. The journal does not offer open access options, which may limit broader dissemination, but it nonetheless remains an important resource for medical professionals, researchers, and students engaging with contemporary medical issues. Located in the vibrant academic landscape of Budapest, ORVOSI HETILAP continues to contribute to the evolving dialogue in the medical community, showcasing diverse topics and fostering interdisciplinary collaboration.